Meclizine Hydrochloride Tablet
Product Images NDC 59651-809

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Meclizine Hydrochloride (NDC 59651-809). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (12.5 mg (100 Tablets Bottle))

FDA Label Image

Package Label-principal Display Panel (25 mg (100 Tablets Bottle))

This text is a description of a medication called Meclizine Hydrochloride. The medication is in the form of tablets and is distributed by Aurobindo Pharma USA, Inc. Each tablet contains 25 mg of Meclizine, with a dihydrochloride equivalent of 21.07 mg of Meclizine free base. The recommended dosage for vertigo is between 25 mg to 100 mg daily, depending on the clinical response. The medication should be kept in a tightly closed, light-resistant container and stored at a temperature between 20°C to 25°C (68°F to 77°F). The text also mentions the need for child-resistant packaging and provides contact information for the distributor.*

FDA Label Image

Package Label-principal Display Panel (50 mg (100 Tablets Bottle))

FDA Label Image

Chemical Structure (Meclazine Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.